nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—CYP2D6—Methimazole—Graves' disease	0.137	0.611	CbGbCtD
Ponatinib—CYP3A4—Methimazole—Graves' disease	0.0871	0.389	CbGbCtD
Ponatinib—FGFR4—connective tissue—Graves' disease	0.0196	0.0548	CbGeAlD
Ponatinib—FGFR4—pituitary gland—Graves' disease	0.0151	0.0423	CbGeAlD
Ponatinib—LYN—connective tissue—Graves' disease	0.0134	0.0376	CbGeAlD
Ponatinib—FGFR3—connective tissue—Graves' disease	0.0134	0.0374	CbGeAlD
Ponatinib—BCR—eye—Graves' disease	0.012	0.0336	CbGeAlD
Ponatinib—FLT3—connective tissue—Graves' disease	0.0115	0.0322	CbGeAlD
Ponatinib—RET—connective tissue—Graves' disease	0.0092	0.0258	CbGeAlD
Ponatinib—FGFR2—eye—Graves' disease	0.00907	0.0254	CbGeAlD
Ponatinib—BCR—pituitary gland—Graves' disease	0.0089	0.0249	CbGeAlD
Ponatinib—BCR—adipose tissue—Graves' disease	0.00886	0.0248	CbGeAlD
Ponatinib—FGFR2—connective tissue—Graves' disease	0.00874	0.0245	CbGeAlD
Ponatinib—TEK—connective tissue—Graves' disease	0.00838	0.0235	CbGeAlD
Ponatinib—FGFR1—pituitary gland—Graves' disease	0.00792	0.0222	CbGeAlD
Ponatinib—FGFR1—adipose tissue—Graves' disease	0.00789	0.0221	CbGeAlD
Ponatinib—SRC—eye—Graves' disease	0.00773	0.0217	CbGeAlD
Ponatinib—BCR—thyroid gland—Graves' disease	0.00767	0.0215	CbGeAlD
Ponatinib—PDGFRA—connective tissue—Graves' disease	0.00759	0.0213	CbGeAlD
Ponatinib—SRC—connective tissue—Graves' disease	0.00744	0.0209	CbGeAlD
Ponatinib—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.00715	0.052	CcSEcCtD
Ponatinib—KDR—eye—Graves' disease	0.00711	0.0199	CbGeAlD
Ponatinib—RET—pituitary gland—Graves' disease	0.00709	0.0199	CbGeAlD
Ponatinib—LCK—adipose tissue—Graves' disease	0.00706	0.0198	CbGeAlD
Ponatinib—KDR—connective tissue—Graves' disease	0.00685	0.0192	CbGeAlD
Ponatinib—FGFR1—thyroid gland—Graves' disease	0.00683	0.0191	CbGeAlD
Ponatinib—FGFR2—adipose tissue—Graves' disease	0.00671	0.0188	CbGeAlD
Ponatinib—TEK—pituitary gland—Graves' disease	0.00646	0.0181	CbGeAlD
Ponatinib—TEK—adipose tissue—Graves' disease	0.00643	0.018	CbGeAlD
Ponatinib—LCK—thyroid gland—Graves' disease	0.00611	0.0171	CbGeAlD
Ponatinib—RET—thyroid gland—Graves' disease	0.00611	0.0171	CbGeAlD
Ponatinib—KIT—connective tissue—Graves' disease	0.00607	0.017	CbGeAlD
Ponatinib—Neuropathy peripheral—Methimazole—Graves' disease	0.006	0.0436	CcSEcCtD
Ponatinib—Jaundice—Methimazole—Graves' disease	0.00596	0.0433	CcSEcCtD
Ponatinib—PDGFRA—adipose tissue—Graves' disease	0.00582	0.0163	CbGeAlD
Ponatinib—FGFR2—thyroid gland—Graves' disease	0.0058	0.0163	CbGeAlD
Ponatinib—SRC—adipose tissue—Graves' disease	0.00571	0.016	CbGeAlD
Ponatinib—TEK—thyroid gland—Graves' disease	0.00557	0.0156	CbGeAlD
Ponatinib—ABL1—eye—Graves' disease	0.00548	0.0154	CbGeAlD
Ponatinib—ABL1—connective tissue—Graves' disease	0.00528	0.0148	CbGeAlD
Ponatinib—KDR—pituitary gland—Graves' disease	0.00528	0.0148	CbGeAlD
Ponatinib—KDR—adipose tissue—Graves' disease	0.00525	0.0147	CbGeAlD
Ponatinib—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.0051	0.037	CcSEcCtD
Ponatinib—Jaundice—Propylthiouracil—Graves' disease	0.00507	0.0368	CcSEcCtD
Ponatinib—PDGFRA—thyroid gland—Graves' disease	0.00504	0.0141	CbGeAlD
Ponatinib—SRC—thyroid gland—Graves' disease	0.00494	0.0139	CbGeAlD
Ponatinib—Alopecia—Methimazole—Graves' disease	0.00485	0.0353	CcSEcCtD
Ponatinib—Haemoglobin—Propylthiouracil—Graves' disease	0.00469	0.0341	CcSEcCtD
Ponatinib—KIT—pituitary gland—Graves' disease	0.00468	0.0131	CbGeAlD
Ponatinib—Haemorrhage—Propylthiouracil—Graves' disease	0.00467	0.0339	CcSEcCtD
Ponatinib—KIT—adipose tissue—Graves' disease	0.00466	0.0131	CbGeAlD
Ponatinib—KDR—thyroid gland—Graves' disease	0.00455	0.0127	CbGeAlD
Ponatinib—Leukopenia—Methimazole—Graves' disease	0.00428	0.0311	CcSEcCtD
Ponatinib—Alopecia—Propylthiouracil—Graves' disease	0.00413	0.03	CcSEcCtD
Ponatinib—Myalgia—Methimazole—Graves' disease	0.00407	0.0296	CcSEcCtD
Ponatinib—Arthralgia—Methimazole—Graves' disease	0.00407	0.0296	CcSEcCtD
Ponatinib—ABL1—pituitary gland—Graves' disease	0.00407	0.0114	CbGeAlD
Ponatinib—ABL1—adipose tissue—Graves' disease	0.00405	0.0114	CbGeAlD
Ponatinib—KIT—thyroid gland—Graves' disease	0.00403	0.0113	CbGeAlD
Ponatinib—Oedema—Methimazole—Graves' disease	0.0039	0.0283	CcSEcCtD
Ponatinib—Thrombocytopenia—Methimazole—Graves' disease	0.00382	0.0278	CcSEcCtD
Ponatinib—Leukopenia—Propylthiouracil—Graves' disease	0.00364	0.0264	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00356	0.0258	CcSEcCtD
Ponatinib—ABL1—thyroid gland—Graves' disease	0.00351	0.00983	CbGeAlD
Ponatinib—Paraesthesia—Methimazole—Graves' disease	0.0035	0.0255	CcSEcCtD
Ponatinib—Myalgia—Propylthiouracil—Graves' disease	0.00346	0.0251	CcSEcCtD
Ponatinib—Arthralgia—Propylthiouracil—Graves' disease	0.00346	0.0251	CcSEcCtD
Ponatinib—Dyspepsia—Methimazole—Graves' disease	0.00343	0.025	CcSEcCtD
Ponatinib—Oedema—Propylthiouracil—Graves' disease	0.00332	0.0241	CcSEcCtD
Ponatinib—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00325	0.0236	CcSEcCtD
Ponatinib—Body temperature increased—Methimazole—Graves' disease	0.00308	0.0224	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00302	0.022	CcSEcCtD
Ponatinib—Paraesthesia—Propylthiouracil—Graves' disease	0.00298	0.0216	CcSEcCtD
Ponatinib—Dyspepsia—Propylthiouracil—Graves' disease	0.00292	0.0212	CcSEcCtD
Ponatinib—Pruritus—Methimazole—Graves' disease	0.00276	0.0201	CcSEcCtD
Ponatinib—CYP2C8—pituitary gland—Graves' disease	0.00264	0.0074	CbGeAlD
Ponatinib—Body temperature increased—Propylthiouracil—Graves' disease	0.00262	0.0191	CcSEcCtD
Ponatinib—ABCG2—pituitary gland—Graves' disease	0.00257	0.00719	CbGeAlD
Ponatinib—ABCG2—adipose tissue—Graves' disease	0.00256	0.00717	CbGeAlD
Ponatinib—Vomiting—Methimazole—Graves' disease	0.00248	0.018	CcSEcCtD
Ponatinib—Rash—Methimazole—Graves' disease	0.00246	0.0179	CcSEcCtD
Ponatinib—Dermatitis—Methimazole—Graves' disease	0.00246	0.0179	CcSEcCtD
Ponatinib—Headache—Methimazole—Graves' disease	0.00244	0.0178	CcSEcCtD
Ponatinib—CYP3A5—adipose tissue—Graves' disease	0.00237	0.00665	CbGeAlD
Ponatinib—Pruritus—Propylthiouracil—Graves' disease	0.00235	0.0171	CcSEcCtD
Ponatinib—Nausea—Methimazole—Graves' disease	0.00232	0.0168	CcSEcCtD
Ponatinib—ABCG2—thyroid gland—Graves' disease	0.00221	0.0062	CbGeAlD
Ponatinib—Vomiting—Propylthiouracil—Graves' disease	0.00211	0.0153	CcSEcCtD
Ponatinib—Rash—Propylthiouracil—Graves' disease	0.00209	0.0152	CcSEcCtD
Ponatinib—Dermatitis—Propylthiouracil—Graves' disease	0.00209	0.0152	CcSEcCtD
Ponatinib—Headache—Propylthiouracil—Graves' disease	0.00208	0.0151	CcSEcCtD
Ponatinib—Nausea—Propylthiouracil—Graves' disease	0.00197	0.0143	CcSEcCtD
Ponatinib—ABCB1—pituitary gland—Graves' disease	0.00127	0.00355	CbGeAlD
Ponatinib—ABCB1—adipose tissue—Graves' disease	0.00126	0.00353	CbGeAlD
Ponatinib—ABCB1—thyroid gland—Graves' disease	0.00109	0.00306	CbGeAlD
Ponatinib—ABCG2—Metabolism—GC—Graves' disease	0.000227	0.000808	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD40—Graves' disease	0.000227	0.000807	CbGpPWpGaD
Ponatinib—LCK—HIV Infection—CD4—Graves' disease	0.000226	0.000803	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CD8A—Graves' disease	0.000226	0.000803	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000225	0.000799	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—HLA-A—Graves' disease	0.000224	0.000797	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CTLA4—Graves' disease	0.000224	0.000796	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—CD4—Graves' disease	0.000223	0.000792	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—IL2RA—Graves' disease	0.000219	0.000778	CbGpPWpGaD
Ponatinib—LYN—Immune System—IFIH1—Graves' disease	0.000219	0.000777	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—IL2RA—Graves' disease	0.000218	0.000775	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IFIH1—Graves' disease	0.000218	0.000773	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—HLA-B—Graves' disease	0.000217	0.000772	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—HLA-E—Graves' disease	0.000214	0.000761	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—CD4—Graves' disease	0.000214	0.00076	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000214	0.00076	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—HLA-A—Graves' disease	0.000213	0.000756	CbGpPWpGaD
Ponatinib—LCK—Disease—B3GNT2—Graves' disease	0.000212	0.000755	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—HLA-A—Graves' disease	0.000212	0.000754	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—HLA-B—Graves' disease	0.00021	0.000748	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CD8A—Graves' disease	0.00021	0.000746	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HLA-E—Graves' disease	0.00021	0.000745	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—HLA-B—Graves' disease	0.000209	0.000744	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000209	0.000741	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000207	0.000735	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000206	0.000733	CbGpPWpGaD
Ponatinib—KIT—Immune System—HLA-E—Graves' disease	0.000206	0.000732	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—HLA-E—Graves' disease	0.000206	0.000731	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD40—Graves' disease	0.000205	0.000728	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000205	0.000728	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL2RA—Graves' disease	0.000204	0.000724	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000203	0.000721	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—HLA-B—Graves' disease	0.000202	0.000718	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CTLA4—Graves' disease	0.000202	0.000718	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD40—Graves' disease	0.000201	0.000715	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—HLA-A—Graves' disease	0.000201	0.000715	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD40—Graves' disease	0.000201	0.000715	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—ICAM1—Graves' disease	0.0002	0.000711	CbGpPWpGaD
Ponatinib—KIT—Immune System—CTLA4—Graves' disease	0.000198	0.000705	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CTLA4—Graves' disease	0.000198	0.000704	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—ICAM1—Graves' disease	0.000197	0.000699	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HLA-E—Graves' disease	0.000196	0.000695	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HLA-E—Graves' disease	0.000195	0.000693	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000194	0.000691	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000194	0.000689	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD40—Graves' disease	0.000191	0.000679	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD40—Graves' disease	0.000191	0.000677	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.00019	0.000676	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CTLA4—Graves' disease	0.000188	0.000669	CbGpPWpGaD
Ponatinib—SRC—Disease—B3GNT2—Graves' disease	0.000188	0.000668	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CTLA4—Graves' disease	0.000188	0.000667	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—HLA-A—Graves' disease	0.000187	0.000665	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—ICAM1—Graves' disease	0.000187	0.000663	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—ICAM1—Graves' disease	0.000186	0.000661	CbGpPWpGaD
Ponatinib—FGFR3—Disease—HLA-A—Graves' disease	0.000186	0.000661	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000184	0.000655	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—HLA-DRB1—Graves' disease	0.000184	0.000654	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TSHR—Graves' disease	0.000183	0.000651	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—IFNG—Graves' disease	0.000182	0.000645	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TSHR—Graves' disease	0.00018	0.00064	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—IL2RA—Graves' disease	0.00018	0.000638	CbGpPWpGaD
Ponatinib—LCK—Immune System—IFIH1—Graves' disease	0.000179	0.000637	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL2RA—Graves' disease	0.000178	0.000632	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—TNF—Graves' disease	0.000177	0.00063	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—ICAM1—Graves' disease	0.000177	0.000627	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—CD4—Graves' disease	0.000175	0.000623	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—HLA-B—Graves' disease	0.000172	0.000613	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—B3GNT2—Graves' disease	0.000172	0.000612	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CXCL10—Graves' disease	0.000172	0.000612	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD8A—Graves' disease	0.000172	0.000612	CbGpPWpGaD
Ponatinib—LYN—Immune System—HLA-E—Graves' disease	0.000172	0.000611	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HLA-E—Graves' disease	0.000171	0.000608	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000171	0.000608	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TSHR—Graves' disease	0.000171	0.000607	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TSHR—Graves' disease	0.00017	0.000606	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.00017	0.000603	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD40—Graves' disease	0.000168	0.000597	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD40—Graves' disease	0.000167	0.000595	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HLA-DQB1—Graves' disease	0.000166	0.000591	CbGpPWpGaD
Ponatinib—LYN—Immune System—CTLA4—Graves' disease	0.000166	0.000589	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—HLA-B—Graves' disease	0.000166	0.000588	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CTLA4—Graves' disease	0.000165	0.000586	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—ICAM1—Graves' disease	0.000164	0.000583	CbGpPWpGaD
Ponatinib—KIT—Immune System—HLA-DQB1—Graves' disease	0.000163	0.000581	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000163	0.00058	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GC—Graves' disease	0.000163	0.000579	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—IL1B—Graves' disease	0.000162	0.000576	CbGpPWpGaD
Ponatinib—FGFR4—Disease—CD4—Graves' disease	0.000162	0.000575	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—IL2RA—Graves' disease	0.000159	0.000565	CbGpPWpGaD
Ponatinib—SRC—Immune System—IFIH1—Graves' disease	0.000159	0.000564	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD8A—Graves' disease	0.000155	0.000552	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HLA-DQB1—Graves' disease	0.000155	0.000551	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HLA-DQB1—Graves' disease	0.000155	0.00055	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—HLA-A—Graves' disease	0.000153	0.000545	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—CD4—Graves' disease	0.000153	0.000544	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—HLA-B—Graves' disease	0.000153	0.000543	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD8A—Graves' disease	0.000153	0.000542	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD8A—Graves' disease	0.000152	0.000542	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—CD4—Graves' disease	0.00015	0.000535	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TSHR—Graves' disease	0.00015	0.000534	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CXCL10—Graves' disease	0.00015	0.000533	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HLA-B—Graves' disease	0.000149	0.000531	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000148	0.000526	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—TNF—Graves' disease	0.000147	0.000523	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—CD4—Graves' disease	0.000147	0.000523	CbGpPWpGaD
Ponatinib—KIT—Immune System—HLA-B—Graves' disease	0.000147	0.000522	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—HLA-B—Graves' disease	0.000147	0.000521	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD8A—Graves' disease	0.000145	0.000515	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—CD4—Graves' disease	0.000144	0.000513	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD8A—Graves' disease	0.000144	0.000513	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—CD4—Graves' disease	0.000143	0.000507	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—CD4—Graves' disease	0.000142	0.000506	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GC—Graves' disease	0.000141	0.000501	CbGpPWpGaD
Ponatinib—LCK—Immune System—HLA-E—Graves' disease	0.000141	0.000501	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—HLA-DRB1—Graves' disease	0.00014	0.000498	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL2RA—Graves' disease	0.00014	0.000498	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HLA-B—Graves' disease	0.000139	0.000495	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HLA-B—Graves' disease	0.000139	0.000494	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HLA-A—Graves' disease	0.000138	0.000492	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD40—Graves' disease	0.000138	0.00049	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL2RA—Graves' disease	0.000138	0.000489	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—CD4—Graves' disease	0.000137	0.000487	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—CD4—Graves' disease	0.000137	0.000486	CbGpPWpGaD
Ponatinib—LYN—Immune System—HLA-DQB1—Graves' disease	0.000136	0.000485	CbGpPWpGaD
Ponatinib—KIT—Immune System—HLA-A—Graves' disease	0.000136	0.000483	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—HLA-A—Graves' disease	0.000136	0.000483	CbGpPWpGaD
Ponatinib—LCK—Immune System—CTLA4—Graves' disease	0.000136	0.000483	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HLA-DQB1—Graves' disease	0.000136	0.000483	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—ICAM1—Graves' disease	0.000135	0.000478	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IFNG—Graves' disease	0.000134	0.000477	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL2RA—Graves' disease	0.000132	0.000468	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL2RA—Graves' disease	0.000131	0.000464	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL2RA—Graves' disease	0.00013	0.000463	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CD4—Graves' disease	0.00013	0.000461	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HLA-A—Graves' disease	0.000129	0.000459	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HLA-A—Graves' disease	0.000129	0.000457	CbGpPWpGaD
Ponatinib—FGFR2—Disease—HLA-A—Graves' disease	0.000128	0.000454	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD8A—Graves' disease	0.000127	0.000453	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD8A—Graves' disease	0.000127	0.000451	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HLA-DRB1—Graves' disease	0.000127	0.00045	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—CD4—Graves' disease	0.000126	0.000446	CbGpPWpGaD
Ponatinib—KIT—Disease—HLA-A—Graves' disease	0.000126	0.000446	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—CD4—Graves' disease	0.000125	0.000444	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-E—Graves' disease	0.000125	0.000443	CbGpPWpGaD
Ponatinib—KIT—Immune System—HLA-DRB1—Graves' disease	0.000124	0.000441	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000124	0.000441	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—B3GNT2—Graves' disease	0.000123	0.000439	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TSHR—Graves' disease	0.000123	0.000438	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GC—Graves' disease	0.000123	0.000437	CbGpPWpGaD
Ponatinib—LYN—Immune System—HLA-B—Graves' disease	0.000123	0.000435	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HLA-B—Graves' disease	0.000122	0.000433	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD40—Graves' disease	0.000122	0.000433	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—ICAM1—Graves' disease	0.000121	0.000431	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CD4—Graves' disease	0.000121	0.000429	CbGpPWpGaD
Ponatinib—SRC—Immune System—CTLA4—Graves' disease	0.00012	0.000427	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL1B—Graves' disease	0.00012	0.000426	CbGpPWpGaD
Ponatinib—FGFR3—Disease—CD4—Graves' disease	0.00012	0.000426	CbGpPWpGaD
Ponatinib—KIT—Immune System—ICAM1—Graves' disease	0.000119	0.000424	CbGpPWpGaD
Ponatinib—FGFR1—Disease—HLA-A—Graves' disease	0.000119	0.000423	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—ICAM1—Graves' disease	0.000119	0.000423	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—HLA-A—Graves' disease	0.000119	0.000422	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CXCL10—Graves' disease	0.000118	0.000421	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HLA-DRB1—Graves' disease	0.000118	0.000419	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HLA-DRB1—Graves' disease	0.000118	0.000418	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CXCL10—Graves' disease	0.000116	0.000413	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GC—Graves' disease	0.000116	0.000412	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL2RA—Graves' disease	0.000115	0.000408	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL2RA—Graves' disease	0.000115	0.000408	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL2RA—Graves' disease	0.000114	0.000406	CbGpPWpGaD
Ponatinib—LYN—Immune System—HLA-A—Graves' disease	0.000114	0.000403	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—ICAM1—Graves' disease	0.000113	0.000402	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HLA-A—Graves' disease	0.000113	0.000402	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—ICAM1—Graves' disease	0.000113	0.000401	CbGpPWpGaD
Ponatinib—LCK—Immune System—HLA-DQB1—Graves' disease	0.000112	0.000397	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CXCL10—Graves' disease	0.00011	0.000392	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CXCL10—Graves' disease	0.00011	0.000391	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TSHR—Graves' disease	0.000109	0.000388	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TNF—Graves' disease	0.000108	0.000385	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—B3GNT2—Graves' disease	0.000107	0.00038	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD8A—Graves' disease	0.000104	0.000371	CbGpPWpGaD
Ponatinib—LYN—Immune System—HLA-DRB1—Graves' disease	0.000104	0.000369	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HLA-DRB1—Graves' disease	0.000103	0.000367	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—CD4—Graves' disease	0.000103	0.000366	CbGpPWpGaD
Ponatinib—LCK—Immune System—HLA-B—Graves' disease	0.0001	0.000357	CbGpPWpGaD
Ponatinib—LYN—Immune System—ICAM1—Graves' disease	9.96e-05	0.000354	CbGpPWpGaD
Ponatinib—ABL1—Immune System—ICAM1—Graves' disease	9.91e-05	0.000352	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-DQB1—Graves' disease	9.9e-05	0.000352	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD4—Graves' disease	9.89e-05	0.000351	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CXCL10—Graves' disease	9.72e-05	0.000345	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TNF—Graves' disease	9.53e-05	0.000339	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TNF—Graves' disease	9.49e-05	0.000337	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL2RA—Graves' disease	9.41e-05	0.000334	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—B3GNT2—Graves' disease	9.32e-05	0.000331	CbGpPWpGaD
Ponatinib—LCK—Immune System—HLA-A—Graves' disease	9.31e-05	0.000331	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD8A—Graves' disease	9.25e-05	0.000328	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IFNG—Graves' disease	9.24e-05	0.000328	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CD4—Graves' disease	9.12e-05	0.000324	CbGpPWpGaD
Ponatinib—KIT—Immune System—IFNG—Graves' disease	9.07e-05	0.000322	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL2RA—Graves' disease	9.06e-05	0.000322	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD4—Graves' disease	8.92e-05	0.000317	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-B—Graves' disease	8.89e-05	0.000316	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL2RA—Graves' disease	8.89e-05	0.000316	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—B3GNT2—Graves' disease	8.78e-05	0.000312	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD4—Graves' disease	8.76e-05	0.000311	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD4—Graves' disease	8.75e-05	0.000311	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	8.75e-05	0.000311	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IFNG—Graves' disease	8.61e-05	0.000306	CbGpPWpGaD
Ponatinib—LCK—Disease—HLA-A—Graves' disease	8.59e-05	0.000305	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IFNG—Graves' disease	8.59e-05	0.000305	CbGpPWpGaD
Ponatinib—LCK—Immune System—HLA-DRB1—Graves' disease	8.5e-05	0.000302	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL2RA—Graves' disease	8.44e-05	0.0003	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL2RA—Graves' disease	8.42e-05	0.000299	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL2RA—Graves' disease	8.33e-05	0.000296	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD4—Graves' disease	8.32e-05	0.000296	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD4—Graves' disease	8.3e-05	0.000295	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL1B—Graves' disease	8.24e-05	0.000293	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-A—Graves' disease	8.24e-05	0.000293	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CD4—Graves' disease	8.24e-05	0.000293	CbGpPWpGaD
Ponatinib—LCK—Immune System—ICAM1—Graves' disease	8.16e-05	0.00029	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL1B—Graves' disease	8.09e-05	0.000288	CbGpPWpGaD
Ponatinib—KIT—Disease—CD4—Graves' disease	8.09e-05	0.000288	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CXCL10—Graves' disease	7.96e-05	0.000283	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL1B—Graves' disease	7.68e-05	0.000273	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CD4—Graves' disease	7.68e-05	0.000273	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL1B—Graves' disease	7.66e-05	0.000272	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CD4—Graves' disease	7.66e-05	0.000272	CbGpPWpGaD
Ponatinib—SRC—Disease—HLA-A—Graves' disease	7.61e-05	0.00027	CbGpPWpGaD
Ponatinib—LYN—Immune System—IFNG—Graves' disease	7.58e-05	0.000269	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GC—Graves' disease	7.57e-05	0.000269	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IFNG—Graves' disease	7.54e-05	0.000268	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-DRB1—Graves' disease	7.53e-05	0.000267	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL2RA—Graves' disease	7.43e-05	0.000264	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD4—Graves' disease	7.32e-05	0.00026	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD4—Graves' disease	7.28e-05	0.000259	CbGpPWpGaD
Ponatinib—SRC—Immune System—ICAM1—Graves' disease	7.23e-05	0.000257	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CXCL10—Graves' disease	7.05e-05	0.00025	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—Graves' disease	6.92e-05	0.000246	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL1B—Graves' disease	6.76e-05	0.00024	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL1B—Graves' disease	6.73e-05	0.000239	CbGpPWpGaD
Ponatinib—LCK—Immune System—IFNG—Graves' disease	6.21e-05	0.000221	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL2RA—Graves' disease	6.09e-05	0.000216	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD4—Graves' disease	6e-05	0.000213	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—B3GNT2—Graves' disease	5.74e-05	0.000204	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL1B—Graves' disease	5.54e-05	0.000197	CbGpPWpGaD
Ponatinib—LCK—Disease—CD4—Graves' disease	5.54e-05	0.000197	CbGpPWpGaD
Ponatinib—SRC—Immune System—IFNG—Graves' disease	5.5e-05	0.000195	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL2RA—Graves' disease	5.39e-05	0.000191	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD4—Graves' disease	5.31e-05	0.000189	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1B—Graves' disease	4.9e-05	0.000174	CbGpPWpGaD
Ponatinib—SRC—Disease—CD4—Graves' disease	4.9e-05	0.000174	CbGpPWpGaD
